| Geld/Brief | 77,74 $ / 118,93 $ |
| Spread | +52,98% |
| Schluss Vortag | 116,33 $ |
| Gehandelte Stücke | 107.149 |
| Tagesvolumen Vortag | 4.164.973 $ |
| Tagestief 118,27 $ Tageshoch 121,86 $ | |
| 52W-Tief 47,91 $ 52W-Hoch 129,80 $ | |
| Jahrestief 66,35 $ Jahreshoch 129,80 $ | |
| Umsatz in Mio. | 39,20 $ |
| Operatives Ergebnis (EBIT) in Mio. | -349,40 $ |
| Jahresüberschuss in Mio. | -311,40 $ |
| Umsatz je Aktie | 0,46 $ |
| Gewinn je Aktie | -3,69 $ |
| Gewinnrendite | -794,39% |
| Umsatzrendite | -794,39% |
| Return on Investment | -17,87% |
| Marktkapitalisierung in Mio. | 9.429 $ |
| KGV (Kurs/Gewinn) | -21,09 |
| KBV (Kurs/Buchwert) | 4,16 |
| KUV (Kurs/Umsatz) | 169,15 |
| Eigenkapitalrendite | - |
| Eigenkapitalquote | +90,64% |
| Handelsplatz | Letzter | Änderung | Vortag | Zeit | |
|---|---|---|---|---|---|
| AMEX | 119,58 $ | +2,92% | 116,19 $ | 18:43 | |
| Nasdaq | 118,54 $ | +1,90% | 116,33 $ | 21:59 | |
| NYSE | 118,48 $ | +1,97% | 116,19 $ | 21:55 | |
| Datum | Kurs | Volumen |
|---|---|---|
| 17.09.26 | 118,54 | 12,8 M |
| 16.09.26 | 116,33 | 4,16 M |
| 15.09.26 | 113,15 | 5,12 M |
| 14.09.26 | 114,63 | 5,06 M |
| 11.09.26 | 114,96 | 4,09 M |
| 10.09.26 | 117,00 | 7,31 M |
| Zeitraum | Kurs | % |
|---|---|---|
| 1 Woche | 117,00 $ | +1,32% |
| 1 Monat | 121,41 $ | -2,36% |
| 6 Monate | 81,21 $ | +45,97% |
| 1 Jahr | 48,16 $ | +146,14% |
| 5 Jahre | 62,95 $ | +88,31% |
| Marktkapitalisierung | 9,43 Mrd. $ |
| Streubesitz | -9,73% |
| Währung | USD |
| Land | USA |
| Sektor | Gesundheit |
| Branche | Biotechnologie |
| Aktientyp | Stammaktie |
| +9,59% | T. Rowe Price Associates, Inc. |
| +9,30% | Baker Bros Advisors LP |
| +9,17% | venBio Select Advisor LLC |
| +7,86% | Vanguard Group Inc |
| +7,70% | Bvf Inc |
| +7,60% | FMR Inc |
| +7,51% | Wellington Management Company LLP |
| +5,80% | BlackRock Inc |
| +5,71% | Atlas Venture Life Science Advisors, LLC |
| +4,79% | Siren, L.L.C. |
| +4,06% | US Small-Cap Growth II Equity Comp |
| +3,73% | T. Rowe Price New Horizons |
| +3,50% | Vanguard Capital Management, LLC |
| +3,49% | Vanguard Portfolio Management, LLC |
| +3,34% | Vanguard Health Care Inv |
| +3,29% | Fidelity Growth Compy Commingled Pl S |
| +2,63% | Vanguard Total Stock Mkt Idx Inv |
| +2,54% | Vanguard Morn Total Stk Mkt Idx Investor |
| +2,52% | Vanguard MStar Total Stk Mkt Idx Invest |
| +2,30% | Fidelity Growth Company Fund |
| +2,17% | State Street Corp |
| +2,03% | Vanguard Small Cap Index |
| +1,77% | Capital Research Global Investors |
| +1,69% | T. Rowe Price Health Sciences |
| +1,67% | Geode Capital Management, LLC |
| +1,58% | iShares Russell 2000 ETF |
| +1,56% | American Funds SMALLCAP World A |
| +1,37% | Vanguard Explorer Inv |
| +1,31% | Driehaus Capital Management LLC |
| +1,30% | T. Rowe Price New Horizons Tr-A |
| +1,24% | State Street® SPDR® S&P® Biotech ETF |
| +1,17% | AllianceBernstein L.P. |
| +1,15% | UBS Asset Mgmt Americas Inc |
| +1,15% | Jennison Associates LLC |
| +1,14% | Vanguard Small Cap Growth Index Inv |
| +1,12% | Redmile Group, LLC |
| +1,08% | Merck & Co Inc |
| +1,06% | Vanguard Morn Small Cap Growth Index Inv |
| +1,05% | Vanguard MStar Small Cap Growth Indx Inv |
| +1,05% | COMMODORE CAPITAL LP |
| +0,97% | T. Rowe Price US Small-Cap Core Equity |
| +0,97% | T. Rowe Price Small-Cap Stock |
| +0,94% | Federated Hermes Inc |
| +0,93% | Holocene Advisors, LP |
| +0,91% | Deerfield Management Co |
| +0,89% | T. Rowe Price Investment Management,Inc. |
| +0,87% | The Goldman Sachs Group Inc |
| +0,80% | T. Rowe Price US All-Cap Opp Eq Comp |
| +0,80% | T. Rowe Price All-Cap Opportunities Fund |
| +0,80% | T. Rowe Price Integrated US SmCapGrEq |
| +0,79% | UBS Group AG |
| +0,79% | Eventide Healthcare & Life Sciences I |
| +0,79% | Dimensional Fund Advisors, Inc. |
| +0,78% | Vanguard Institutional Extnd Mkt Idx Tr |
| +0,75% | T. Rowe Price Integrated US Sm Gr Eq |
| +0,74% | Fidelity Contrafund |
| +0,73% | PGIM Jennison Health Sciences Z |
| +0,73% | Jennison Health Sciences Equity |
| +0,71% | Fidelity Growth Company K6 |
| +0,68% | Fidelity Small Cap Index |
| +0,68% | SPDR® S&P Biotech ETF |
| +107,472% | Institutionelle Aktionäre |
| +2,257% | Insider Aktionäre |
| -9,729% | Streubesitz |
